Below is a list of links and short descriptions of our recently run webinars produced by Meridian Bioscience. These are hosted on the Vimeo website and each webinar will open in a new, dedicated window.
The Importance of Diagnostics in Pertussis Outbreak Situations
This program will provide a comprehensive overview of Bordetella pertussis and discuss the benefits of having molecular detection with illumigene Pertussis by Meridian Bioscience during a community outbreak situation.
Actualités dans le diagnostic du paludisme d’importation : Illumigene Malaria lève le doute!
Docteur Pierre Hance: Médecin biologiste Labosud Provence Biologie, spécialiste des Hôpitaux des Armées, Diplômé de l'Institut Pasteur. Cette conférence reviendra sur les différentes techniques de diagnostic du paludisme et sur l’intérêt d’utiliser la biologie moléculaire pour la détection d’espèces du genre Plasmodium.
Clinical Study Experience with illumigene® HSV 1&2
Belinda Yen-Lieberman, Ph.D. and Donna Mayne, B.S. MT (ASCP), CLS (NCA) will discuss the performance of a loop-meditated isothermal amplification (LAMP) assay (illumigene reg; HSV 1&2) for the diagnosis of HSV 1&2 compared with that of ELVIS in mucocutaneous and cutaneous swab specimens. The recently FDS-cleared illumigene HSV 1&2 assay provides highly sensitive and specific results in less than pne hour to reduce turnaround time and eliminate the need for send-outs and viral culture.
Campylobacter Enteritis and Laboratory Methods for Its Diagnosis – Is There a Best Way?
Meridian Bioscience, Inc. Foodborne Webinar Series. Key Opinion Leader, Paul A. Granato, Ph.D., DABMM, FAAM provides a comprehensive review of Campylobacter Enteritis and Laboratory Methods for Its Diagnosis.
"LEANING" The Diagnosis Of Group A Strep & The Diagnostic Challenges of Bordetella pertussis
Meridian Bioscience Respiratory Webinar Series - This program will provide a comprehensive overview of Group A Streptococcus & Bordetella pertussis and the benefits of molecular detection.
How does a False Negative EHEC test result put your hospital and your patients at RISK?
Michael B. Lytle, BS, M(ASCP) presents. Register now for this live webinar on Tuesday 25th and Thursday 27th March 2014.
Group B Strep Screening Update: Guidelines and Methods
Key opinion leader, Haywood Brown, MD, Professor and Chair, Obstetrics, Gynecology and Maternal Fetal MedicineDuke Medicine, Durham, NC, presents on the topic of Group B Streptococcal disease. Group B Streptococcus continues to be the leading cause of morbidity and mortality in infants. This program will provide a comprehensive overview of this pathogen and the 2010 CDC guidelines that address diagnosis and prevention.
Neonatal Group B Streptococcal Disease: Problem Solved?
Group B Streptococcus continues to be the leading cause of morbidity and mortality in infants. This program will provide a comprehensive overview of this pathogen and the 2010 CDC guidelines that address diagnosis and prevention.
Molecular Biology in the diagnosis of Clostridium difficile
Worldwide, Clostridium difficile continues to be a leading cause of hospital acquired infections. C. difficile key opinion leader, Katelijne Floré, M.D. presents the topic of Molecular Biology in the Diagnosis of Clostridium difficile.
Group A Streptococcus - The Benefits of Molecular Detection
Key Opinion leader Jennifer Dien Bard, Ph.D., D(ABMM), FCCM discusses Group A Streptococcus continues to be the number one cause of acute bacterial pharyngitis. This program will provide a comprehensive overview of this pathogen and the benefits of molecular detection along with the 2012 IDSA Guidelines that address diagnosis and treatment.
Shiga Toxigenic E. coli: A Fully Emerged, Still Underappreciated Pathogen
Key opinion leader, Marc Roger Couturier, Ph.D., D(ABMM), provides a comprehensive review of Shiga Toxigenic E. coli: A Fully Emerged, Still Underappreciated Pathogen.
Laboratory and Clinical Experience of Utilizing a Molecular C. difficile Assay
In this first European Webinar Dr. Noren reports on his experience of the past year, speaking about the performance of our molecular assay compared to toxigenic culture and discussing the benefits of a rapid turnaround time in CDI diagnosis.
Campylobacteriosis: An Overview and Update on Laboratory Diagnosis
Paul Granato, Ph.D., DABMM, FAAM, presents comprehensive review of Campylobacter, including modes of transmission, symptoms, and virulence factors. This program will also discuss the advantages and disadvantages of the different test methods currently available.
Group B Streptococcus: Disease, Guidelines and Testing Options
Key opinion leader, Donna Mayne, B.S. (MT) ASCP, (CLS) NCA, presents on the topic of Group B Streptococcus. She discusses disease state, guidelines for testing and testing options.
STEC: Why You Should Be Screening For More Than O157
Key opinion leader, Michael B. Lytle, BS, M(ASCP) provides a comprehensive review of Shiga-toxin producing E. coli including modes of transmission, symptoms, and virulence factors. This webinar will also discuss the advantages and disadvantages of the different test methods currently available.
Detecting Clostridium difficile: What are the recommendations and What are our options?
C. difficile key opinion leader Wallace Greene, PhD, (ABMM) presents the topic - Detecting Clostridium difficile and addressing what are the recommendations and what are your options for testing.